Research Leadership Council
The RLC has responsibility for coordination, planning, and oversight of HCI’s research portfolio and is accountable for the design and execution of Cancer Center goals. The Council is chaired by the Cancer Center Director and includes representatives from the Director’s Cabinet, all Cancer Program Leaders, Staff Investigators, HCI-managed Shared Resource Directors, the PRMS and DSMC Chairs, and senior administrators. This group serves as the core leadership of the Cancer Center, participates actively in strategic planning for HCI research initiatives, and directs evaluation of Programs, Shared Resources, and membership. New applications for Cancer Center Membership are presented by a relevant Cancer Program Leader and put forward for an advisory vote by RLC members based on specific membership criteria; Dr. Ulrich makes final decisions on Cancer Center membership. The RLC meets monthly for two hours.
The Huntsman Cancer Institute’s Research Leadership Council is composed of the following leadership categories:
Chair
- Cornelia Ulrich, PhD, Director, Comprehensive Cancer Center, HCI
HCI Senior Directors
- Bradley R. Cairns, PhD, Basic Science
- Martin McMahon, PhD, Pre-Clinical Translation
- Michael W. Deininger, MD, PhD, Transdisciplinary Research
- David K. Gaffney, MD, PhD, Clinical Research
- Kathleen Mooney, PhD, Population Sciences
- Scott Lloyd, MBA, CPA, Finance and Administration
- David W. Wetter, PhD, MS, Community Engagement and Cancer Health Equity Research
- Kolawole S. Okuyemi, MD, MPH, Diversity and Inclusion
- Donald E. Ayer, PhD, Cancer Training Innovation
Program Co-Leaders
Nuclear Control of Cell Growth and Differentiation
- Bradley R. Cairns, PhD
- Jared P. Rutter, PhD
Cell Response and Regulation
- Alana L. Welm, PhD
- Sheri L. Holmen, PhD
Experimental Therapeutics
- Neeraj Agarwal, MD
- Martin McMahon, PhD
Cancer Control and Population Sciences
- Kathleen Mooney, PhD, RN
- Sean V. Tavtigian, PhD
Clinical Leaders
- Paul J. Shami, MD, Chair, Data and Safety Monitoring
- Wallace L. Akerley, MD, Chair, Protocol Review and Monitoring
Shared Resource Directors
- Carolyn Ross and Jen Heninger, Research Informatics
- Wendy K. Kohlmann, MS, CGC, Genetic Counseling
- David H. Lum, PhD, Preclinical Research Resource
- Brian Dalley, PhD, and David A. Nix, PhD, High-Throughput Genomics and Bioinformatic Analysis
- Christopher Fillmore, PhD, Biorepository and Molecular Pathology
- Kenneth M. Boucher, PhD and Benjamin Haaland, PhD, Cancer Biostatistics
- Ken R. Smith, PhD, Utah Population Database
Staff Investigators
- Lisa A. Cannon-Albright, PhD
- Jennifer A. Doherty, MS, PhD
Administration
- Maxwell Loveless, MBA, Director, Research Administration
- Ellen T. Wilson, PhD, Director, Research Development
HCI Centers and Partners
Center for Health Outcomes and Population Equity (HOPE)
- David W. Wetter, PhD, MS, Director
Center for Investigational Therapeutics
- Neeraj Agarwal, MD, Director
Center for Quantitative Cancer Imaging
- John M. Hoffman, MD and Jeffrey T. Yap, PhD, Directors
Utah Cancer Registry
- Jennifer A. Doherty, PhD, MS, Director,
Center for Patient and Public Education
- Donna M. Branson, Director